Everest Organics
EVERESTO
Live Everest Organics Share Price Chart
Everest Organics Performance
Days Range
| Previous Close | ₹231.60 |
|---|---|
| Open | ₹231.00 |
| Volume | 37 |
| Day's Range | ₹225.10 - ₹233.35 |
|---|---|
| 52W Range | ₹197.00 - ₹536.40 |
| Market Cap | ₹230.99 Cr |
Everest Organics Fundamentals
| ROCE(TTM) | 11.62 |
|---|---|
| P/E Ratio (TTM) | 43.95 |
| P/B Ratio | 2.91 |
| Industry P/E | 48.05 |
| Debt to Equity | 0.66 |
| ROE | 7.35 |
| EPS (TTM) | 5.27 |
| Dividend Yield | N/A |
| Book Value | 79.69 |
| Face Value | 10 |
| ROCE(TTM) | 11.62 |
|---|---|
| P/E Ratio (TTM) | 43.95 |
| P/B Ratio | 2.91 |
| Industry P/E | 48.05 |
| Debt to Equity | 0.66 |
| ROE | 7.35 |
|---|---|
| EPS (TTM) | 5.27 |
| Dividend Yield | N/A |
| Book Value | 79.69 |
| Face Value | 10 |
Everest Organics Financials
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Sales | 51.00 | 42.59 | 48.75 | 48.43 |
| Expenses | 47.39 | 40.57 | 43.98 | 45.69 |
| Profit before tax | 2.67 | 1.04 | 2.17 | 1.53 |
| Operating Profit | 1.16 | 0.36 | 2.63 | 1.11 |
| Net Profit | 1.16 | 0.36 | 2.63 | 1.11 |
| EPS in Rs | 1.19 | 0.37 | 2.69 | 1.15 |
Everest Organics Shareholding Pattern
Promoters
60.61%
Retail And Others
39.37%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.02%
About Everest Organics
Everest Organics was incorporated at Hyderabad in Feb.'93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju.
The company set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project.
Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enrofloxacin/naproxen.
The company has increased its installed capacity of Benzimidazole by 60 tpa there by taking its capacity to 120 tpa.The installed capacity of Omeprazole Op Sulphide was increased from 15 TPA to 30 TPA.
Parent Organisation
Indian Private
Managing Director
Srikakarlapudi Sirisha
Founded
1993
NSE Symbol
Top Mutual Funds Invested in Everest Organics Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,752.3 7.20 (0.41%) | ₹4,18,683.95 | 1,583.7 - 2,046.9 |
| Divis Laboratories Ltd | 9,119.0 -71.00 (-0.77%) | ₹2,42,903.75 | 5,647.5 - 9,740.0 |
| Torrent Pharmaceuticals Ltd | 4,605.4 51.60 (1.13%) | ₹1,72,213.45 | 3,532.6 - 5,250.0 |
| Zydus Lifesciences Ltd | 1,137.0 19.70 (1.76%) | ₹1,11,451.10 | 835.5 - 1,232.1 |
| Laurus Labs Ltd | 1,998.3 -14.20 (-0.71%) | ₹1,08,710.82 | 902.35 - 2,089.0 |
| Cipla Ltd | 1,328.4 14.40 (1.10%) | ₹1,06,138.04 | 1,165.7 - 1,673.0 |
Popular Stocks
Everest Organics Ltd FAQs
Can I buy Everest Organics Ltd (Everest Organics Ltd) from Angel One?
Yes, You can buy Everest Organics Ltd (Everest Organics Ltd) shares by opening a Demat account with Angel One.
How do I buy Everest Organics Ltd (Everest Organics Ltd) from Angel One?
Everest Organics Ltd (Everest Organics Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Everest Organics Ltd (Everest Organics Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Everest Organics Ltd (Everest Organics Ltd) shares.
1. Direct investment: You can buy Everest Organics Ltd (Everest Organics Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Everest Organics Ltd (Everest Organics Ltd) shares.
